NCT00724542View on ClinicalTrials.gov

Evaluation of Intervention on Impaired Glucose Tolerance(IGT) in Patients With Coronary Heart Disease.

NAUnknownINTERVENTIONAL
Enrollment

1,600

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Coronary Heart DiseaseImpaired Glucose Tolerance
Interventions
DRUG

Voglibose tablets

0.2mg Tid

Trial Locations (1)

100034

RECRUITING

Peking University First Hospital, Beijing

Sponsors

Collaborators (1)

Takeda
All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

Ministry of Science and Technology of the People´s Republic of China

OTHER_GOV